前线超CVAD加Venetoclax用于儿科的囊性等离子体 树突细胞新生体
Jiasen He1, Miriam B Garcia1, Jeremy S Connors1
1Division of Pediatrics.
Journal of pediatric hematology/oncology
|September 4, 2023
概括
囊性血细胞状树突细胞瘤 (BPDCN) 是一种罕见的儿童癌症. 在一个涉及中枢神经系统的病例中,修改后的超CVAD疗法与venetoclax实现了缓解.
科学领域:
- 血液学恶性瘤是什么
- 儿科瘤学 儿科瘤学
- 免疫型定型 免疫型定型
背景情况:
- 囊性血细胞状树突细胞瘤 (BPDCN) 是一种罕见的血液性恶性瘤,儿科治疗数据有限.
- 由于呈现的变化和独特的免疫表型 (CD4,CD56,TCF4,TCL-1,CD123+),BPDCN诊断可能具有挑战性.
研究的目的:
- 报告儿科BPDCN的病例,涉及多个部位.
- 描述一种新型治疗方案的成功使用情况.
- 为突出儿童BPDCN的潜在一线治疗方法.
主要方法:
- 一个患有BPDCN的儿科患者的病例报告.
- 用修改过度CVAD (高分离环胺,温克里斯,多克索鲁比辛,德克萨米他) 加维尼托克拉克斯和内化疗进行治疗.
- 异性干细胞移植.
主要成果:
- 患者实现了完全缓解.
- 患者在干细胞移植200天后仍然没有疾病.
- 这是第一个在前线环境中使用这种修改后的治疗方案报告的儿科病例.
结论:
- 修改过度CVAD与venetoclax是一个潜在的有效的前线治疗儿科BPDCN.
- 这种方案可能为中枢神经系统,轨道和皮肤参与的患者提供一个有前途的选择.
- 需要进一步的研究,以在更大的队列中验证这种方法.
相关概念视频
Continuous Renal Replacement Therapy
54
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
54
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
![Dynamic Imaging of Chimeric Antigen Receptor T Cells with [18F]Tetrafluoroborate Positron Emission Tomography/Computed Tomography](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F62334.jpg&w=3840&q=50)

